A Randomized Phase 3 Study Comparing Pemetrexed Plus Cisplatin With Gemcitabine Plus Cisplatin as First-Line Treatment in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2014
At a glance
- Drugs Cisplatin; Gemcitabine; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2010 Planned end date changed from 1 Jul 2013 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 17 May 2010 Planned end date changed from Sep 2013 to Jul 2013 as reported by ClinicalTrials.gov.